InterMune taps banks as it braces for buyout bids -sources
August 13, 2014 at 13:13 PM EDT
NEW YORK, Aug 13 (Reuters) - Biotechnology company InterMune Inc is working with financial advisers to evaluate strategic options as it braces for potential takeover interest from larger drugmakers, people familiar with the matter said.
